Abel Hall LLC Purchases 83 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Abel Hall LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 933 shares of the healthcare conglomerate’s stock after purchasing an additional 83 shares during the quarter. Abel Hall LLC’s holdings in UnitedHealth Group were worth $546,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in UNH. State Street Corp grew its stake in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after acquiring an additional 35,533 shares during the last quarter. International Assets Investment Management LLC grew its position in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in UnitedHealth Group by 0.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after buying an additional 21,149 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 5.1 %

Shares of NYSE UNH opened at $549.62 on Monday. The stock has a market capitalization of $505.80 billion, a P/E ratio of 35.81, a P/E/G ratio of 1.61 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a 50-day moving average price of $586.84 and a 200-day moving average price of $559.07.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.56 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.63 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.53%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on UNH. Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Stephens upped their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, TD Cowen lifted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $626.84.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.